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EDITORIAL REVIEW
Role of peritoneal cavity lymphatic absorption in peritoneal
dialysis
The number of patients with end—stage renal disease on
peritoneal dialysis therapy continues to increase [1]. Although
transcapillary peritoneal transport of water and solutes in
CAPD has been widely studied since its inception in 1976 [2, 31,
the role of lymphatic absorption from the peritoneal cavity in
peritoneal dialysis has been neglected. Calculations of mass
transfer of solutes are based on the observed drainage volume
and dialysate solute concentration. Removal of water and
sodium in peritoneal dialysis is dependent on the net ultrafiltra-
tion volume at the end of the exchange. Assuming residual
volume remains constant, the drain volume after a peritoneal
dialysis exchange is equal to the infused dialysate volume plus
net transcapillary peritoneal transport of water and solute,
minus cumulative lymphatic absorption during the dwell time
(Fig. 1); the ultrafiltration volume is equal to net transcapillary
ultrafiltration minus lymphatic drainage during the dwell time.
Consequently, disregarding the reduction in drain volume due
to lymphatic drainage can cause considerable errors in calcu-
lating actual peritoneal transport in physiological experiments
and, more important clinically, excessive lymphatic absorption
may be a significant factor in the loss of ultrafiltration observed
in some CAPD patients. This review aims to summarize current
knowledge of the anatomy and physiology of the peritoneal
cavity lymphatics and to provide evidence which supports the
concept that cumulative lymphatic absorption during long—
dwell, peritoneal dialysis exchanges reduces net ultrafiltration
volumes and solute clearances.
Anatomy
Lymphatic drainage of particles, red blood cells and labelled
plasma protein from the peritoneal cavity occurs mainly from
end lymphatics (stomata) located in the diaphragm, especially
in the right half around the liver [4—6]. Absorption through the
rest of the parietal peritoneum, mesenteric, and omental lym-
phatics contributes a small proportion of total peritoneal lym-
phatic drainage [6—8]. Stomata on the peritoneal surface of the
diaphragm were first observed over a century ago by von
Recklinghausen [9] and the presence of these specialized end
lymphatic openings has since been confirmed by scanning and
transmission electron microscopy [10—121. The lymphatic sto-
mata are triple—layer composite structures consisting of meso-
thelium, a loose network of connective tissue, and endothelium
through which particles and colloids pass to the lacunae of
lymphatic capillaries [10, 12]. The intercellular gaps that de-
velop between the mesothelial and endothelial cells adjacent to
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stomata [10, 12] and the fenestrations in the submesothelial
connective tissue and basement membrane [13] permit absorp-
tion via an extracellular pathway, although vesicular transport
may also occur [12]. The lymphatic capillaries coalesce to form
collecting lymphatics and prenodal lymphatic trunks. Most of
the lymphatic trunks from the diaphragm travel retrosternally
along with the internal mammary arteries to the anterior
mediastinal lymph nodes and return 80% of the peritoneal
lymphatic drainage to the venous circulation via the right lymph
duct [7, 14]. The lymphatic drainage from the remainder of the
peritoneum, including part of the diaphragm, is returned to the
bloodstream via the thoracic duct [7]. Cannulation of the
thoracic duct during peritoneal dialysis in animals collected less
than 30% of total peritoneal lymphatic drainage [15, 161. Ob-
struction of both the right lymph duct and thoracic duct does
not prevent all intraperitoneal labelled protein from returning to
the blood [7], and suggests that other small lymphatico-venous
communications remain intact. These lymphatic pathways of
absorption of intraperitoneal fluid are summarized in Figure 2.
Function
The lymphatics act as a one—way system which returns
excess interstitial and serous fluid to the blood vascular system.
Water may transfer across the peritoneal capillaries in either
direction, depending on the hydrostatic and oncotic (colloid
osmotic) pressure gradients between the blood and interstitium.
Net transcapillary pressure (zP) may be written:
1P=(PcPp)(Tc1Tp);
where P = capillary hydrostatic pressure, P, = hydrostatic
pressure in the peritoneal interstitium, i = oncotic pressure in
the capillaries and lTp = oncotic pressure in the peritoneal
interstitium. Movement of water from interstitium to the pen-
toneal cavity will depend on the same pressure forces across the
mesothelium separating the fluid in the peritoneal cavity from
the interstitium. Bidirectional transfer of small solutes occurs
by diffusion along the concentration gradient and by solvent
drag.
Large colloid molecules of molecular weight greater than
20,000 exhibit transperitoneal transport asymmetry [17] and
thus minimal direct absorption into the capillaries. After unidi-
rectional transport from capillaries by filtration through large
pores and/or pinocytosis [17, 18] macromolecules such as
albumin are transported back from the peritoneal interstitium
and cavity to the venous circulation by the lymphatics [19, 201.
Such is the importance of lymphatic absorption of interstitial
protein that it has been estimated that 50% of the total blood
protein is returned from the tissue spaces by the lymphatic
system each day [21], and in hepatic cirrhotics with ascites,
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Fig. 1. Solute and water transport in peritoneal dialysis. Solute mass
transfer for solutes not initially present in the dialysis solution equals
drained dialysate solute concentration x drain volume (drain volume
dialysate infusion volume + net transcapillary transport — lymphatic
absorption during dwell time). Ultrafiltration volume equals net trans-
capillary transport — lymphatic absorption during dwell time.
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Fig. 2. Anatomical pathways of lymphatic absorption of intraperitoneal
fluid. Lymph returns to venous circulation via (R) lymph duct (70 to
80%), thoracic duct (20 to 30%) and small lymphatico-venous junctions
(<5%).
9 6% of the intravascular protein mass is returned to the
bloodstream from the peritoneal cavity each day [22]. Since
lymphatic drainage of tissue or serous fluid normally equals its
rate of formation, interstitial edema or serous effusions do not
p
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Fig. 3. Changes in osmolality and intraperitoneal fluid volume after
infusion of O9% NaCI. Equilibration volume (point A) coincides with
crystalloid osmotic equilibrium (point B). Mixed venular absorption
refers to fluid absorption due to both crystalloid and colloid osmotic
pressure.
develop and only a small volume of isosmotic fluid is normally
maintained in the peritoneal cavity.
Intraperitoneal fluid kinetics
Solute and water kinetics have been studied when isotonic
and hypertonic solutions are instilled in the peritoneal cavity.
When isotonic saline solution was infused intraperitoneally in
three uremic subjects [23] and in 11 dehydrated dogs [241, the
initial rapid, transcapillary fluid absorption gradually decreased
until transperitoneal osmotic equilibrium was reached (Fig. 3).
Thereafter the isosmotic fluid was absorbed at a constant rate of
33 mI/h in man [23] and 16 8 mI/h in the dog [24]. This
absorption phase is thought to be mainly due to peritoneal
lymphatic drainage.
In contrast, hypertonic dextrose solutions are routinely used
in peritoneal dialysis, and the crystalloid osmotic pres-
sure—gradient predominates and alters transcapillary pressure
to induce ultrafiltration, That is:
where O, = crystalloid osmotic pressure in capillaries and O, =
crystalloid osmotic pressure in the peritoneal interstitium.
Movement of ultrafiltrate into the peritoneal cavity would
depend on similar relationships of interstitial to peritoneal
cavity pressure—gradients. The peritoneal membrane is not
equally permeable to all solutes in dialysis fluid and thus the
osmotic pressure gradient is the sum of the products of the
reflection coefficient and concentration gradient for each solute.
Since ultrafiltration occurs, water and solute movement from
peritoneal capillaries into the peritoneal cavity by way of
pathways through the interstitium must bypass absorption by
the interstitial lymphatics. In fact, some ultrafiltrate might come
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Fig. 4. Changes in osmolality and intraperitoneal fluid volume after
infusion of 2.5% dextrose dialysis solution. Peak intraperitoneal volume
(ultrafiltration) represented by point A precedes crystalloid osmotic
equilibrium (point B). At peak ultrafiltration, lymphatic absorption rate
equals transcapillary ultrafiltration rate.
from interstitial lymphatics subsequent to the osmotic effects of
interstitial glucose.
In peritoneal dialysis the net transcapillary ultrafiltration rate
is maximum at the onset of the exchange and decreases
exponentially as the crystalloid osmotic pressure—gradient dis-
sipates. The intraperitoneal volume increases until it reaches a
maximum when the rate of transcapillary transport equals the
rate of peritoneal lymphatic absorption (Fig. 4). After peak
ultrafiltration, transcapillary efflux continues at a slow rate until
crystalloid osmotic equilibrium is approached later in the dial-
ysate dwell time. Net reabsorption begins when the lymphatic
absorption rate exceeds the transcapillary ultrafiltration rate
and continues after crystalloid osmotic equilibrium. Under both
of the above conditions fluid flux during the equilibration phase
is primarily dependent on the crystalloid osmotic pressure
gradient since intravascular hydrostatic pressure, capillary
oncotic pressure and peritoneal permeability/area remained
relatively constant. For any given patient on peritoneal dialysis,
increases in osmolality of the dialysate result in prolongation of
the time until crystalloid osmotic equilibrium is achieved,
increase in peak ultrafiltration volume, and delay until net
intraperitoneal fluid reabsorption begins [25, 26], even though
the lymphatic absorption rate is unlikely to have decreased.
Osmotic equilibrium is first reached in peritoneal dialysis
before glucose equilibrium since there is sieving of small solutes
with ultrafiltration [2]. Further net transcapillary absorption of
dextrose occurs because of the glucose concentration gradient.
Simultaneously there is transcapillary net efflux of small solutes
(sodium, potassium, urea, phosphate) because of concentration
gradients subsequent to sieving. After crystalloid osmotic equi-
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Fig. 5. Net ultrafiltration (UF) and lymphatic reabsorption rates during
25% dextrose dialysate dwell. Lymphatic reabsorption is assumed to be
constant. Point A represents maximum intraperitoneal volume when
the net ultrafiltration (UF) rate is zero. Point B indicates time when
dialysate/plasma osmolality ratio is I, and point C represents time when
dialysate/plasma glucose is 1.
librium, there may be a transient phase where dialysate is low in
electrolytes due to mixing with low electrolyte ultrafiltrate and
dialysate is hypoosmolar to serum. In this same phase, dialy-
sate glucose may still exceed serum glucose, and because of the
higher reflection coefficient for glucose compared to other
smaller solutes [27], some net transcapillary ultrafiltration con-
tinues. Hence intraperitoneal net fluid reabsorption near os-
motic equilibrium initially represents lymphatic absorption in
excess of transcapillary ultrafiltration (Fig. 5). Later, Gibbs—
Donnan equilibrium is approached, net transcapillary ultrafil-
tration falls to zero and venular reabsorption begins due to
serum oncotic pressure. Late phase reabsorption has been
reported to average 37 mI/hr (range 8 3 to 89 2 ml/hr) [261.
Although transcapillary (venular) fluid absorption due to trans-
membrane oncotic pressure near crystalloid equilibration is
likely to be minor, lymphatic absorption in peritoneal dialysis,
unlike the above studies with isotonic solutions [23, 24], cannot
be assumed to equal the rate of decrease of intraperitoneal
volume after maximum ultrafiltration since this rate represents
lymphatic flow minus net transcapillary ultrafiltration. Thus the
lymphatic absorption rate in peritoneal dialysis should be
calculated directly.
Calculation of lymphatic absorption
The measurement of the peritoneal lymphatic flow rate is
dependent on certain assumptions:
1. Isosmotic intraperitoneal fluid is drained by the peritoneal
lymphatics without increase or decrease in protein content
[16, 22, 28—30].
2. Intraperitoneal red cells [14, 161 and macromolecules of
molecular weight greater than 20,000 [16, 17], such as
albumin [7, 31, 32], are returned to the venous circulation
exclusively by the peritoneal lymphatics.
Hence the peritoneal lymphatic absorption rate can be calcu-
lated from either the rate of mass transfer of labelled colloids
and red cells from the peritoneal cavity to the blood or from
their rate of disappearance from the peritoneal cavity. Perito-
neal to plasma clearance of tracer may be written:
VD x CDFL= c
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where FL = total peritoneal lymphatic flow during time
of study;
VD = volume of distribution (blood volume);
CD = rise in tracer concentration in blood volume;
Cp average intraperitoneal tracer concentration.
By this method, intraperitoneal radio-iodinated serum albu-
min (RISA) [22, 33, 341 and radio-colloid [34—36] have been
used to measure lymphatic flow rates in hepatic [22, 341,
malignant [34—361 and nephrogenic ascites [331. Adequate intra-
peritoneal mixing [33] of the tracer and intra-individual repro-
ducibility [34] of these methods have been shown. After an
initial lag phase radiolabelled protein concentrations in the
blood increase linearly with time [22, 33, 341 as predicted.
However, all of the absorbed tracer cannot be recovered from
the blood [16]. Radiolabelled proteins, but not red cells, are
redistributed out of the blood volume [16] and so their elimina-
tion rate (KELIM) from the blood compartment after intravenous
administration should be included in order to calculate the
lymphatic absorption rate more accurately [16, 17]. Intact
human red—blood cells (7
.tdiameter) are readily absorbed by
the peritoneal lymphatics [14], and KELIM zero [16]. However
red cells (and particles) may be fixed by omental macrophages
and lymph nodes [37] and are absorbed at a slower rate than
plasma when compared in the rat [161. Since lymphatic pene-
trability is less in man [38] than in the rat (lymphatic uptake of
plastic spheres up to 24 .t diameter [13]), the rate of peritoneal
lymphatic absorption is even more likely to be underestimated
in man when measured using labelled red cells. Estimates of
peritoneal lymphatic flow rate by this method [16], are consis-
tently lower than direct observation of absorption of intraperi-
toneal plasma or blood [4].
Alternatively the peritoneal lymphatic absorption rate may be
calculated from the rate of loss of tracer colloid from the
peritoneal cavity [16]. That is:
(IPV0 x C0) — (IPV1 x C1)FL —
Cp
where FL = total peritoneal lymph flow during time t;
IPV0 & IPV intraperitoneal fluid volumes at times 0
and t;
C0 & C = intraperitoneal tracer concentrations at times
0 and t;
C, = geometric mean intraperitoneal tracer
concentation.
This method avoids errors in calculating lymph flow due to
delayed transfer of tracer from the submesothelial interstitial
lymphatics and diaphragm to the blood (16). The disadvantages
of this method are errors in estimating intraperitoneal volumes
and the need for serial samples of intraperitoneal fluid. The
latter is easily achieved in peritoneal dialysis since the patients
have peritoneal catheters in situ, and we are currently applying
this method in our institution.
Despite ligature of both the right lymph and thoracic ducts, a
small amount of intraperitoneal dye—protein enters the blood
[39], suggesting either direct absorption of the dissociated label
[39], the presence of unobstructed small, accessory lymphat-
ico—venous connections [7], or a small exchange of protein
directly from tissue fluids into the blood capillaries [40]. This
Table 1. Criteria for an ideal indicator—dilution method of calculating
peritoneal lymphatic flow rate
1. Tracer is ONLY absorbed by the lymphatics.
2. Tracer does not aggregate and is well mixed throughout intra-
peritoneal volume.
3. Tracer label does not dissociate from carrier macromolecules or
cells in tissue fluids.
4. Tracer is non-toxic.
5. Tracer is diluted in large enough volume to ensure continuous
contact with subdiaphragmatic lymphatics.
6. Low coefficient of variation on repeat measurements under the
same experimental conditions.
Table 2. Factors shown to increase peritoneal lymphatic flow rate
I. Raised intraperitoneal hydrostatic pressure.
2. Raised diaphragmatic movement (hyperventilation).
3. Supine posture.
4. After chemical peritonitis.
may equally apply to tracers used in both of the above methods
of calculating lymphatic absorption. Hence neither labelled red
cells nor proteins fulfill all of the criteria listed in Table 1 for an
ideal indicator of the rate of mass lymphatic transfer from the
peritoneal cavity. In general lymphatic flow rates measured by
the appearance of an indicator in the blood tend to be underes-
timated whereas the disappearance rate of an indicator from the
peritoneal cavity tends to overestimate lymphatic absorption.
Despite these limitations, a number of variables have been
shown to influence the lymphatic flow rate, determined by the
above methods, and these factors have important implications
for the mechanism of peritoneal lymph formation.
Factors altering lymphatic absorption
The factors which determine peritoneal cavity lymphatic
absorption rate have been studied mainly in animal experiments
[28, 39, 41—47]. Both peritoneal transcapillary and lymphatic
absorption rates are increased with raised intraperitoneal hy-
drostatic pressure [28] and are decreased after paracentesis
[48]. Lymphatic absorption rate is highly dependent on dia-
phragmatic movement. Hyperventilation induced by breathing
CO2 increases [41], whereas phrenic neurectomy and anesthe-
sia decrease lymphatic absorption [41, 42]. Upright posture
with small intraperitoneal volumes [39] is associated with
reduced rates of lymphatic flow although absorption still oc-
curs. Numerous patent diaphragmatic stomata were observed
when relaxation of the diaphragm was induced by suc-
cinylcholine and when the intraabdominal pressure was raised,
whereas few patent stomata were noted when the diaphragm
was fixed in contraction by carbachol [43]. It is therefore
postulated that suction created by distension of the diaphrag-
matic lacunae in expiration absorbs peritoneal fluid [44], which
is subsequently emptied into the efferent lymphatics during
inspiration when the diaphragm contracts and intrathoracic
pressure is negative 143, 45]. Valves in the lymphatic ducts
maintain forward flow [10, 44] induced by changes in the
intrathoracic pressure and by lymphatic contractility. Chemical
peritonitis induced by sodium hypochlorite increased the rate of
lymphatic absorption in the recovery period [46], perhaps
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related to rapid regeneration of end lymphatics after injury [47].
In ascites and peritoneal dialysis the large intraperitoneal vol-
umes ensure continuous contact with the subdiaphragmatic
surface and, even when ambulatory, provide conditions for high
lymphatic drainage. Factors which increase peritoneal lym-
phatic flow—rate are summarized in Table 2.
Peritoneal lymphatics in ascites
Although the importance of lymph flow in the pathogenesis of
hepatic [22, 49—52] and malignant ascites [34, 35, 53] has been
recognized, the role of lymphatic absorption in peritoneal
dialysis has been disregar&d. In hepatic cirrhosis, peritoneal
lymphatic flow increases before ascites develops [491 and
ascites only results after overflow of hepatic and intraabdominal
regional lymph into the peritoneal cavity (due to increased
hepatic sinusoidal and portal hydrostatic pressure and de-
creased serum oncotic pressure) exceeds peritoneal lymphatic
drainage [49—51]. This lymph imbalance accords with both the
classic and overflow theories of the pathogenesis of hepatic
ascites [54] and is also self—perpetuated by salt and water
retention stimulated by a relative decrease in intravascular
volume as ascites accumulates. Although lymph flow is in-
creased in hepatic ascites [49, 50, 55], there appears to be an
upper limit to the rate of absorption [50, 51, 56]. This is most
likely due to progressively increased resistance to lymphatic
flow as the absorption rate rises since, although the thoracic
duct becomes dilated [55], the ostium of the thoracic duct at the
junction of the (L) internal jugular and subclavian veins remains
fixed in diameter (56). Cannulation of the thoracic duct resulted
in increased lymphatic flow rates in hepatic ascites [55] and in
rats infused with intraperitoneal Krebs—Ringer solution [16].
Hepatic ascites has been successfully treated by bypassing this
narrowing at the lymphatico-venous junction [57, 58] and by
peritoneo-venous shunting [59] which increase the lymphatic
flow rate directly and indirectly, respectively. Increased central
venous pressure secondary to right heart failure or fluid over-
load reduces the pressure gradient for lymph flow into the
innominate veins [56], and may explain the decreased lymphatic
absorption rate that has been reported in nephrogenic ascites
[33]. Although the mechanism of increased lymphatic drainage
(up to 20 liter/day) in hepatic ascites is not understood, the
reduced peritoneal lymphatic absorption observed in malignant
ascites [34, 35] is presumed secondary to obstruction of the
diaphragmatic lymphatics and draining lymph nodes by metas-
tases [34, 35, 53].
Lymphatic flow rate in peritoneal dialysis
In contrast the contribution of peritoneal lymphatic absorp-
tion to net solute mass transfer and ultrafiltration in peritoneal
dialysis "ascites" is not well established (Table 3). The mean
lymphatic flow rate, determined by the rate of transfer of RISA
from peritoneal cavity to plasma, in 10 CAPD patients was 11
1 mlthr (range 4 8 to 16 6 ml/hr) [60]. However, these results
may not be accurate since the elimination rate of RISA from
plasma was not included in the calculations, the plasma vol-
umes of these uraemic patients were estimated from their body
weight, and the fractional plasma absorption rate was only 20%
of the peritoneal disappearance rate. Although this method
underestimates peritoneal lymphatic absorption, the above re-
sults may be compared with average lymphatic flow rates of 62
mi/hr in hepatic ascites [22], 11 mI/hr in malignant ascites [34]
and 15 mI/hr in nephrogenic ascites [33]. Other studies in
peritoneal dialysis in man have shown a wide variation in
peritoneal transcapillary [61—63] and lymphatic transport [63].
Small increments in hydrostatic pressure in tissues other than
the peritoneal cavity increased the lymphatic flow rate until a
maximum was reached when tissue pressure was 2 mm Hg
above normal [64]. Submesothelial edema is observed in CAPD
and may be expected to contribute to increased fluid absorption
by interstitial lymphatics in the peritoneal membrane. Raised
intraperitoneal volume may increase lymphatic absorption by
increasing intraperitoneal hydrostatic pressure and may also
explain the elevated peritoneal lymphatic flow rate frequently
observed in hepatic ascites [22]. In ascites peritoneal lymphatic
absorption rates of greater than 50 mI/hr would be expected
unless there were abnormalities in either the diaphragmatic or
mediastinal lymphatics [34]. In peritoneal dialysis the rate of
decrease of intraperitoneal volume after peak ultrafiltration
represents lymphatic absorption in excess of net transcapillary
ultrafiltration, and averaged 37 mI/hr in 16 CAPD patients [26].
It would therefore not be unexpected if the daily peritoneal
lymphatic flow rate in CAPD "ascites" was greater than 1 liter
per day, This accords with the results of our preliminary study
of peritoneal lymphatic flow rates in six CAPD patients (unpub-
lished). The lymphatic absorption rate was calculated from the
rate of removal of intraperitoneal albumin during an exchange
using 2 liter, 2.5% dextrose peritoneal dialysis solution with 30
g added albumin (human serum albumin). The mean lymphatic
absorption rate was 85 mI/hr and net (measured) ultrafiltration
at the end of the four hour dwell time averaged 329 ml. These
results indicate that lymphatic drainage during the four hour
dwell reduced the volume of net transcapillary ultrafiltration
that could be drained at the end of the exchange by 51%, and
thus confirm that ultrafiltration volume is significantly de-
creased by cumulative lymphatic absorption during the ex-
change.
However, the delayed effect of CAPD on lymph flow rate
remains speculative. If lymphatic absorption increases, solute
clearances and observed drainage volume (ultrafiltration) would
decrease. These detrimental kinetics are observed in some
CAPD patients [61, 62, 65] and are usually attributed to change
in the peritoneal membrane, either hyperpermeability, rapid
dialysate glucose absorption and early dissipation of the os-
motic gradient [62, 66] or sclerosis of the membrane [67—70],
rather than elevated lymphatic drainage. Even if lymphatic
absorption rate remains unchanged with time on CAPD, it may
become relatively more important and clinically significant if
the above changes in the peritoneal membrane result in de-
creased transperitoneal efflux of water and solutes. Net trans-
capillary ultrafiltration is known to continue in such patients
[62, 661, since net ultrafiltration can be observed if the exchange
time (and thus cumulative lymphatic drainage) is reduced.
Thus, an increase in cumulative lymphatic absorption and/or
reduction in cumulative, net transcapillary ultrafiltration (62,
66—70) will result in loss of ultrafiltration. We suspect that
ultrafiltration failure occurs when daily lymphatic absorption
equals or exceeds daily, net transcapillary ultrafiltration.
Since the mesothelium and endothelium of the diaphragmatic
stomata contain actin filaments [44, 71] and the lymphatic ducts
have both intrinsic contractility [72] and innervation by non-
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Table 3. Transcapillary fluid flux and lymphatic
absorption rates in ascites
Ascites
Transcapillary
fluid efflux into
peritoneal cavity
Peritoneal
lymphatic
flow rate
Hepatic
Malignant
Nephrogenic
Peritoneal dialysis
+-l-+
+
+
+ + +
++
—
?
Abbreviations are: + increase; — decrease.
myelinated autonomic fibers [73], lymphatic flow rate may be
amenable to pharmacological control. Drugs are delivered to
lymphatic ducts by the vasa lymphorum [74] as well as lymph,
so oral or parenteral medication may alter lymph flow. Al-
though neural blockade by tetrodotoxin had little effect on
spontaneous lymphatic contractility [73], inherent myogenicity
was decreased by aspirin and indomethacin and increased by
leukotrienes and prostaglandin F2a [74]. These latter products
of inflammation are found in the dialysate during peritonitis [75]
and so loss of ultrafiltration during episodes of peritonitis may
be due to increased lymphatic absorption rate as well as
enhanced peritoneal membrane permeability and rapid glucose
absorption. The contractility of isolated lymphatic vessels was
decreased when the calcium antagonist, 0-600, was added to
the bathing medium [761. Whether intraperitoneal vasoactive
drugs significantly alter lymphatic as well as blood vessel
smooth muscle tone and contractility in vivo remains unknown.
Alternative osmotic agents with less transcapillary absorp-
tion than glucose have been sought to induce more effective
ultrafiltration in peritoneal dialysis [77]. Although macromol-
ecules of molecular weight greater than 19,400 have minimal
transcapillary uptake [17], bulk transport via the peritoneal
lymphatics means that these macromolecules will still be ab-
sorbed, albeit more slowly, and so be potentially toxic system-
ically. The lymphatic absorption and systemic accumulation of
macromolecules, such as gelatins and glucose polymer, have
precluded their clinical use as effective osmotic agents. Simi-
larly, any particulate matter [78—80] that is present in the
dialysis solution may also be absorbed by the peritoneal lym-
phatics, although systemic absorption is likely to be less
marked than in hemodialysis where direct transfer via the
hemodialyzer blood path can occur. Nevertheless this further
underlines the importance of minimizing contaminants in com-
mercial peritoneal dialysis solutions.
Bacteria have been observed in thoracic duct lymph in dogs
within 10 minutes of intraperitoneal injection [81] and have been
recovered in the intrathoracic lymph nodes of patients who
have died of peritonitis [82]. Absorption by the peritoneal
lymphatics and phagocytosis by resident intraperitoneal mac-
rophages are the major first lines of defence after a bacterial
inoculum enters the peritoneal cavity [83], since polymorpho-
nuclear leucocyte influx into the peritoneal cavity is delayed for
one to two hours, and sequestration of bacteria by adhesions
and fibrin trapping only occurs if infection persists. Conse-
quently thoracic duct ligation reduced bacterial clearance [83],
whereas omentectomy had no effect on lymphatic absorption of
graphite particles [43]. Despite peritoneal lymphatic absorption,
blood cultures during CAPD peritonitis are rarely positive, and
pulmonary infections or right sided endocarditis secondary to
peritonitis are seldom encountered [84, 85]. It is presumed that
the infectious agents are filtered and trapped in the draining
lymph nodes. Hence, absorption via the peritoneal lymphatics
makes a major contribution to the host defenses of the perito-
neal cavity without predisposing the patient on peritoneal
dialysis to systemic infections.
Although the physiological role of the lymphatics in improv-
ing host defences and maintaining a small volume of isosmotic
fluid in the peritoneal cavity is presumably beneficial, ultrafil-
tration and solute kinetics in peritoneal dialysis may be influ-
enced adversely by peritoneal cavity lymphatic absorption.
Since lymphatic drainage in peritoneal dialysis has been
underinvestigated, further studies are needed to determine if
cumulative lymphatic absorption during the dwell time signifi-
cantly reduces net ultrafiltration volumes and solute clearances.
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